Journal News

A jellyfish model to study optogenetics

Adenike Shittu
By Adenike Shittu
Dec. 26, 2023

Box jellyfish, an ancient invertebrate species, have evolved separately from vertebrate animals for over 500 million years. Unlike other jellyfish species, box jellyfish have well-developed eyes similar to those of vertebrates. These eyes have a light-sensitive protein receptor called rhodopsin that enables them to process visual cues such as twilight and color perception, which are essential for their survival.

Shino Inukai, Kota Katayama, Hideki Kandori and colleagues at the Nagoya Institute of Technology in Japan have found that the rhodopsin in jellyfish is similar to that in vertebrates. In a recent article published in the Journal of Biological Chemistry, they describe the structural similarities, photoreaction activity and highly developed visual function of rhodopsin in box jellyfish and vertebrates.

Box jellyfish have the only animal rhodopsin known to activate Gs protein. G proteins are guanine nucleotide-binding proteins. They can transmit signals from receptors on the cell surface to the inside of the cell, where they regulate a wide range of cellular functions and processes. These include maintenance of cellular homeostasis, response to external stimuli, neurotransmission and sensory perception.

Box jellyfish’s rhodopsin, or JelRh, is the only animal rhodopsin that researchers have shown to transduce the G protein signaling pathways. Because jellyfish rhodopsin can control the G proteins’ signaling pathway with light, it is a promising new optogenetics tool.

The authors used JelRh to study how G proteins regulate cyclic adenosine monophosphate induction, or cAMP, which is widely associated with biological processes such as circadian rhythms, cardiac function and behavioral control. In the words of the authors, “the development of jellyfish rhodopsin can be used as a tool to elucidate the molecular mechanisms of diseases caused by abnormal signal transduction through Gs protein,” which include nephrogenic diabetes insipidus and obesity.

While this study shows promising findings, the authors acknowledge certain limitations in this model. The authors’ discovery of JelRh’s distinctive hydrogen bonding network surrounding the retinal chromophore hints at intermediate structural variance in rhodopsin in other invertebrates and vertebrates.

Researchers have not yet characterized other essential defining factors of JelRh. Therefore, as a future work, the authors propose to conduct site-directed mutation measurements to determine the key residues, in GPCR activation. Future structural studies will focus on the photoreaction of the active state to explore how JelRh triggers Gs protein–mediated phototransduction cascade. Specifically, the spectroscopy-based structural study of photoreaction dynamics of Gs-coupled animal rhodopsin will provide insights into the activation mechanism of G protein–coupled receptors.

Looking forward, the team proposes to clarify the light activation and signal transduction mechanisms of JelRh, the only animal rhodopsin that has been shown to transduce Gs signal. Specifically, the aim is to decipher the molecular intricacies underlying the activation of Gs protein.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Adenike Shittu
Adenike Shittu

Adenike Shittu is a biomedi­cal research scientist who is passionate about science communication and an ASBMB Today contributing writer.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Spider-like proteins spin defenses to control immunity
News

Spider-like proteins spin defenses to control immunity

Oct. 17, 2025

Researchers from Utrecht University discovered two distinct binding modes of a spider-shaped immune inhibitor found in serum.

A biological camera: How AI is transforming retinal imaging
Feature

A biological camera: How AI is transforming retinal imaging

Oct. 15, 2025

AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.

AI in the lab: The power of smarter questions
Essay

AI in the lab: The power of smarter questions

Oct. 14, 2025

An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Feature

Training AI to uncover novel antimicrobials

Oct. 9, 2025

Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Journal News

AI-designed biomarker improves malaria diagnostics

Oct. 8, 2025

Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Journal News

Matrix metalloproteinase inhibitor reduces cancer invasion

Oct. 8, 2025

Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.